/ Not yet recruitingNot Applicable A Multi-centre, double blind, randomized placebo controlled phase II study to assess the efficacy and safety of ASCT01 in Critical limb Ischemia Patients - SCILI - SCILI
100 Clinical Results associated with XCell-Center GmbH
0 Patents (Medical) associated with XCell-Center GmbH
100 Deals associated with XCell-Center GmbH
100 Translational Medicine associated with XCell-Center GmbH